Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete
莱姆病螺旋体假定调节因子的机制和功能分析
基本信息
- 批准号:10316195
- 负责人:
- 金额:$ 22.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-09 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AreaArthritisBiological AssayBorreliaBorrelia burgdorferiCarditisChromosomesChronicClinicalDataEnvironmentFutureGene ExpressionGene Expression RegulationGene TargetingGenesGenomeGoalsHealthHeartHumanImmunofluorescence ImmunologicImpairmentIn VitroInbred C3H MiceInfectionInflammationIntercistronic RegionInvestigationJointsKnowledgeLeadLife Cycle StagesLipoproteinsLyme DiseaseLyme InfectionMammalsMapsMediatingMessenger RNAMethodsMissionMusMutation AnalysisNatureNorth AmericaNymphOrder SpirochaetalesOspC proteinPathogenesisPathologyPeripheralPlasmidsProcessProductionProteinsProteomePublic HealthPublishingQuantitative Reverse Transcriptase PCRRNARegulationRepressionResearchRoleSystemTestingTicksTimeTissuesTranscriptUnited States National Institutes of HealthUntranslated RNAVector-transmitted infectious diseaseVirulenceWorkbasedisabilityenzooticexpression cloninghost colonizationhuman pathogenimprovedinnovationmutantnew therapeutic targetnovelpathogenpreventtherapeutic developmenttranscriptome sequencingvector tick
项目摘要
Summary
The ability of Borrelia burgdorferi to cause Lyme disease is highly dependent on its capacity to establish a
successful infection upon entering the mammalian host. Moreover, survival of the Lyme disease pathogen in
nature is completely dependent on its enzootic life cycle involving both a tick vector and reservoir host. The
transition between these two very different environments requires the ability to rapidly adapt through changes
in gene expression. Recent studies in our lab have provided evidence that the functional product of the bbd07
intergenic region of lp17 acts as a small non-coding RNA (sRNA) important for host adaptation. Despite this
advance, there remains a fundamental gap in our understanding of the mechanistic aspects of bbd07-mediated
gene regulation, and the genes subjected to its regulatory effects are unknown. Our long-term goals are to
identify and characterize factors necessary for B. burgdorferi adaptation to the tick and mammalian host
environments. The overall objective of this application is to establish the importance of bbd07 for regulation of
genes important for host colonization by B. burgdorferi. Based on preliminary data, the central hypothesis of
this proposal is that bbd07 acts as a sRNA essential for regulation of genes known to be important for host
adaptation. The rationale for the proposed research is that bbd07 RNA and the gene products under its
regulatory influence represent potential targets for the development of therapeutics against human infection by
the pathogen, as well as disruption of its enzootic life cycle. Thus, the proposed research is relevant to that
part of NIH’s mission that pertains to developing fundamental knowledge that will potentially help to reduce the
burdens of human illness and disability. Guided by published and preliminary data, our hypothesis will be
tested by pursuing the following two specific aims: 1) Determine the regulatory mechanism of bbd07 and
identity of additional target genes, and 2) Establish a correlation between bbd07 expression and ospC
repression during host infection. Under the first aim, the 5’ end of bbd07 RNA will be characterized by RACE,
sRNA-mRNA target interactions will be mapped, and iTRAQ analysis will be used to determine the large-scale
effects of bbd07 deletion on the B. burgdorferi proteome. Under the second aim, the relative levels of bbd07
and ospC expression in the murine and ticks hosts will be quantified, and OspC production visualized using an
immunofluorescence assay. The proposed work is innovative because it utilizes a novel RNA-seq-based
method to globally map sRNA-mRNA target interactions in B. burgdorferi, and is the first mutational analysis of
bbd07 to assess its respective importance for regulation of genes involved in host adaptation. When applied,
the knowledge gained from the proposed studies has the potential to elucidate new drug targets to treat and
prevent Lyme disease.
总结
伯氏疏螺旋体引起莱姆病的能力高度依赖于其建立一种免疫系统的能力。
在进入哺乳动物宿主后成功感染。此外,莱姆病病原体在
自然界完全依赖于其包括蜱虫媒介和储库宿主的地方性生活周期。的
在这两种截然不同的环境之间过渡,需要具备通过变化快速适应的能力
in gene基因expression表达.我们实验室最近的研究提供了证据,证明BBD 07的功能产物
lp 17的基因间区域作为对宿主适应重要的小的非编码RNA(sRNA)起作用。尽管如此
虽然我们对bbd 07介导的
基因调控,以及受其调控作用的基因是未知的。我们的长期目标是
确定和表征B所需因素。布格氏蜱对蜱和哺乳动物宿主的适应
环境.本申请的总体目标是确定bbd 07对于调节
对宿主被B定殖重要的基因。burgdorferi。根据初步数据,
这一建议是bbd 07作为一种sRNA,对调节已知对宿主重要的基因至关重要,
适应。这项研究的基本原理是,bbd 07 RNA及其基因产物可以在细胞内表达。
监管影响是开发抗人类感染疗法的潜在目标,
病原体,以及破坏其地方性生活周期。因此,拟议的研究与此相关
NIH的使命的一部分,涉及到发展基础知识,这将可能有助于减少
人类疾病和残疾的负担。根据已发表的和初步的数据,我们的假设将是:
通过追求以下两个具体目标进行测试:1)确定bbd 07的调节机制,
另外的靶基因的同一性,和2)建立bbd 07表达和ospC之间的相关性
在宿主感染期间的抑制。在第一个目标下,bbd 07 RNA的5'端将通过RACE表征,
将绘制sRNA-mRNA靶点相互作用,并使用iTRAQ分析来确定大规模相互作用
bbd 07缺失对B.伯氏菌蛋白质组在第二个目标下,bbd 07的相对水平
将定量鼠和蜱宿主中的OspC表达,并使用免疫组织化学方法观察OspC产生。
免疫荧光测定。这项工作是创新的,因为它利用了一种新的基于RNA-seq的方法。
在B中全局映射sRNA-mRNA靶相互作用的方法。burgdorferi,是第一个突变分析,
bbd 07,以评估其各自对参与宿主适应的基因的调节的重要性。当应用时,
从拟议的研究中获得的知识有可能阐明新的药物靶点,
预防莱姆病。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Potential Regulatory Role in Mammalian Host Adaptation for a Small Intergenic Region of Lp17 in the Lyme Disease Spirochete.
- DOI:10.3389/fcimb.2022.892220
- 发表时间:2022
- 期刊:
- 影响因子:5.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Troy Michael Bankhead其他文献
Troy Michael Bankhead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Troy Michael Bankhead', 18)}}的其他基金
Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
- 批准号:
10473671 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Functional and Mechanistic Studies of the VlsE-mediated Immune Avoidance System in the Lyme Disease Spirochete
莱姆病螺旋体 VlsE 介导的免疫回避系统的功能和机制研究
- 批准号:
10371053 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10373101 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
- 批准号:
10188845 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10188065 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8836954 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8611524 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
9247117 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8501363 - 财政年份:2012
- 资助金额:
$ 22.95万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8354084 - 财政年份:2012
- 资助金额:
$ 22.95万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:














{{item.name}}会员




